Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patritumab with Cetuximab and Platinum Therapy in SCCHN
NCT02350712Phase 1Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Dec 2014
- Primary completion
- Mar 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, open-label trial of patritumab in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Daiichi Sankyo Co., Ltd. Started Dec 2014; status: completed.
02
Drugs
patritumab
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT02350712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02350712.